The Economist article claimed: “Phase-three trials yielded an efficacy rate (for the Chinese vaccine Sinovac) of just 50.7 percent.” The article’s title made it a tabloid piece: “In clinical and real world trials, China’s Sinovac underperforms.” The clear message: Sinovac doesn’t work; avoid it. As such this Economist fake news is so despicable. The Economist though didn’t report those figures, which were way above the World Health Organization’s minimum 50-percent efficacy requirement for vaccines. The silver lining, as it were, though of that Economist fake news is this: Sinovac, as well as the other vaccines, do not automatically immune you 100 percent from Covid-19. ScienceThe Economist didn’t report these figures, of course, as it would have obviously revealed its report was fake news.

Source: Manila Times April 27, 2021 16:18 UTC